Back to User profile » Dr Hongzhen Zhang
Paper published by Dr Hongzhen Zhang:
Original Research
Feasibility Study of Pyrrolitinib-Based Dual-Target Therapy for Neoadjuvant Treatment of HER2-Positive Breast Cancer Patients
Zhao F, Zhang H
Breast Cancer: Targets and Therapy 2024, 16:845-853
Published Date: 29 November 2024